Classic Kaposi's sarcoma in Jews living in Israel, 1961–1989: a population‐based incidence study

@article{Iscovich1998ClassicKS,
  title={Classic Kaposi's sarcoma in Jews living in Israel, 1961–1989: a population‐based incidence study},
  author={Jos{\'e} Iscovich and Paolo Boffetta and Regina Winkelmann and Paul J Brennan and Esther Azizi},
  journal={AIDS},
  year={1998},
  volume={12},
  pages={2067–2072}
}
Background:The incidence of classic Kaposi's sarcoma (CKS) has been reported to be high in Jewish populations, mostly born in Eastern Europe. Objective:To describe the incidence on CKS in Israeli Jews and to determine differences in incidence according to their geography origin. Design:We analysed data on 1098 incident CKS cases with known country of origin occurring between 1961 and 1989 in the Jewish Israeli population. Reporting systems were the Israel Cancer Registry, the medical… 

Epidemiology of Kaposi's sarcoma in Iran: 1984-2006.

Although, there were no published reports about HHV-8 or HIV/AIDS associated with KS in Iran, the elderly might be a common associated factor for KS.

Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology

In Morocco, CKS exhibits some special characteristics including a disseminated skin disease at diagnosis especially in men, a more common visceral or lymph node involvement and a less frequent association with second malignancies.

Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998

Trends in the incidence of classic Kaposi's sarcoma in the Jewish population in Israel for the period between 1960 and 1998 were analysed and the highest incidence rates were displayed by men originated from Africa and by Asian-born women.

Classic Kaposi's sarcoma as a second primary neoplasm

The trend toward increased risk after a short time lapse and the difference in risk among immigrants indicate that genetic susceptibility is part of the complex interplay between cellular proliferation and control systems.

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

The presence of K SHV in Jews in Israel of all ethnic origins and their high incidence of reported Kaposi's sarcoma suggest that KSHV was introduced into the Jewish population prior to the major Diaspora.

Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007

This large retrospective study provides further insight into Kaposi's sarcoma, finding Ethnicity and date of diagnosis are important predictors of long-term survival.

Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City.

The KSHV seroprevalence was not elevated among elderly Jews, despite their known high risk for Kaposi's sarcoma, but among KSHv-seropositive individuals, K8.1 titres were highest in subgroups at greatest risk for KS and may identify individuals with poor immune control of K SHV replication during asymptomatic infection.

Risk of Kaposi sarcoma among immigrants to Sweden.

This study reports mean age at diagnosis and KS rates by site in first-generation immigrants to Sweden, suggesting underreporting of KS or the existance of some unknown protective factors for KS.

Kaposi Sarcoma: A review of 387 cases seen in Yaounde, Cameroon

HIV serology is recommended for all patients who present with a Kaposi sarcoma and concomitantly, all HIV seropositive patients should be screened for the disease.
...

References

SHOWING 1-10 OF 23 REFERENCES

Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome

It is questionable whether immune dysfunction due to other malignant disease or drug therapy can account for the epidemiologic changes in KS, which began almost 2 decades prior to the AIDS epidemic in Sweden.

Epidemiology of Classic Kaposi's Sarcoma, with Special Reference to Mediterranean Population

The present review deals with epidemiologic data concerning KS in the Mediterranean and stresses the opportunity to combine the study of KS in AIDS as well as non-AIDS patients in order to shed light on this no longer rare disease.

Kaposi's sarcoma in Italy before and after the AIDS epidemic.

The incidence of Kaposi's sarcoma in 1976-90 was assessed in Italy, taking advantage of a network of nine population-based cancer registries covering, at its maximum, approximately 5.6 million subjects, to suggest that the prevalence of the still unknown causative agent for KS was high, at least in some parts of Italy, prior to the AIDS epidemic.

Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic.

It is argued that environmental factors play an important role in the development of the disease Kaposi's sarcoma and cannot be explained by registrational procedures or known risk factors for KS.

Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.

The KS case rate among never-married men younger than 50 years old, a surrogate index of homosexuality, was found to be markedly elevated in the post-AIDS period, compared with the case rate of a reference disease, mycosis fungoides.

Kaposi's sarcoma in Los Angeles, California.

The demographic characteristics of "classic" Kaposi's sarcoma (KS) and of "epidemic" KS in Los Angeles, CA, were compared with the use of data from the Cancer Surveillance Program, the population-based tumor registry to demonstrate that the demographic risk factors of religion and birthplace for classic KS are unrelated to epidemic KS.

Epidemiological characteristics of Kaposi's sarcoma prior to the AIDS epidemic.

The overall annual incidence of Kaposi's sarcoma was 0.47 per million, and the highest incidence was in people born in the Middle East and in males born in southern and eastern Europe.

Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution

Over the quinquennium 1964-68 the crude annual incidence of Kaposi's sarcoma in Uganda per million of the population was 7·9 overall, 14·6 for males and 1·1 for females. Statistical analysis

Cancer in Kampala, Uganda, in 1989–91: Changes in incidence in the era of aids

The most striking feature is the emergence of Kaposi's sarcoma as the leading cancer in males and the second most frequent in females, which parallels the evolution of the epidemic of AIDS.

Kaposi's sarcoma.

Kaposi's Sarcoma (KS) remains an enigma over 100 years after it was first described by a Hungarian dermatologist who ensured his place in the hall of fame by changing his name to the exotic 'Kaposi',